Effects of Exercise Therapy Adjuvant Device on Head and Neck Cancer Patients in the Treatment of Cancer Therapy Induced Trismus

Sponsor
Taipei Medical University (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT04740216
Collaborator
(none)
130
2
28.6

Study Details

Study Description

Brief Summary

Trismus is traditionally considered being a late effect of cancer therapy with functional deficits becoming clear in the first year after completing radiation therapy. These deficits can rapidly progress to a state of functional impairment. The most common treatment for trismus is physical therapy comprising an active range of motion (ROM) exercises, hold and relax techniques. Once trismus has developed, it may be hard to reverse. Thus, prevention with a program of self-care is important for managing this side effect. This study want to test the effect with adjunctive devices plus exercise to prevent trismus.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: exercise therapy plus jaw device
  • Behavioral: exercise therapy
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
130 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Double (Participant, Outcomes Assessor)
Primary Purpose:
Treatment
Official Title:
A Randomized Feasibility Trial to Test Exercise Therapy Plus Jaw Device to Prevent Trismus in Patients With Head and Neck Cancer Receiving Radiation-Based Therapy
Anticipated Study Start Date :
Feb 10, 2021
Anticipated Primary Completion Date :
Feb 10, 2023
Anticipated Study Completion Date :
Jun 30, 2023

Arms and Interventions

Arm Intervention/Treatment
Experimental: exercise therapy plus jaw device

exercise therapy plus jaw device

Behavioral: exercise therapy plus jaw device
The mouth-opening rehabilitation exercise lasts for twelve weeks, five days a week, three times a day. Subjects can arrange to perform before or after meals according to personal eating time and preferences. The experimental group performs 30 minutes each time, including 20 minutes of stretching exercises. Ten-minute mouth expander assisted passive exercise.

Placebo Comparator: exercise therapy

exercise therapy

Behavioral: exercise therapy
the control group performed 20-minute stretching exercises each time.

Outcome Measures

Primary Outcome Measures

  1. The change of maximum interincisal opening (MIO) [baseline, 2 weeks, 4 weeks, 6 weeks, 8weeks, 10 weeks, 12 weeks, 6 months.]

    Using Gothenburg Trismus Questionnaire, GTQ to measure the trismus condition and mouth opening

Secondary Outcome Measures

  1. The change of fatigue level [baseline, 2 weeks, 4 weeks, 6 weeks, 8weeks, 10 weeks, 12 weeks, 6 months.]

    using the Brief Fatigue Inventory, BFI to measure fatigue level

  2. Quality of life (QOL) [baseline, 2 weeks, 4 weeks, 6 weeks, 8weeks, 10 weeks, 12 weeks, 6 months.]

    using the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire-Core 30 Head and Neck 35-questions, EORTC-QLQ-C30-H&N35 to meaure QOL

Eligibility Criteria

Criteria

Ages Eligible for Study:
20 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  1. Age is greater than or equal to 20 years old.

  2. Those who are able to communicate in Mandarin and Taiwanese and have no reading or listening or writing disabilities can fill out the questionnaire by themselves or with the assistance of the researcher.

  3. Diagnosed with head and neck cancer, and is expected to receive head and neck radiation therapy for the first time.

  4. A clear consciousness, no severe cognitive impairment or mental symptoms.

  5. Willing to participate in this research and obtain consent.

Exclusion Criteria:
  1. People with known temporomandibular joint disorders.

  2. The maximum opening degree is less than or equal to 25 mm.

  3. Those who have received radiotherapy for the head and neck in the past.

  4. Those who have been diagnosed by a physician for poor wound healing after surgery and unable to perform mouth-opening rehabilitation exercises.

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

  • Taipei Medical University

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Tsai-Wei Huang, Principal Investigator, Clinical Professor, Taipei Medical University
ClinicalTrials.gov Identifier:
NCT04740216
Other Study ID Numbers:
  • B202005159
First Posted:
Feb 5, 2021
Last Update Posted:
Feb 5, 2021
Last Verified:
Feb 1, 2021
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Tsai-Wei Huang, Principal Investigator, Clinical Professor, Taipei Medical University
Additional relevant MeSH terms:

Study Results

No Results Posted as of Feb 5, 2021